Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
Heinz Ludwig(Wilhelminen Hospital), Sonja Zweegman(Vrije Universiteit Amsterdam), Hermann Einsele(Universitätsklinikum Würzburg), Mario Boccadoro(University of Turin), Jesús F. San Miguel(Clinica Universidad de Navarra), Thierry Façon(Université de Lille), Torben Plesner(University of Southern Denmark), Joan Bladé(Hospital Clínic de Barcelona), Meral Beksaç(Ankara University), Meletios Α. Dimopoulos(Korea University), Pia Sondergeld(Faringdon Day Hospital), U Hess(Université Paris Cité), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Hartmut Goldschmidt(Heidelberg University), Ofer Shpilberg(Texas Oncology), Michèle Cavo(Unknown), Nicolas Ketterer(Centre Hospitalier Universitaire Vaudois), Gareth J. Morgan(Hywel Dda University Health Board), Johannes Drach(Vienna General Hospital), Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), Jean‐Luc Harousseau(Institut de Cancérologie de l'Ouest), Martin Kropff(University Hospital Münster), Jamie Cavenagh(St Bartholomew's Hospital), Pieter Sonneveld(Erasmus MC Cancer Institute)
Cited by 92
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k